Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | JNJ-87890387 |
Trade Name | |
Synonyms | JNJ 87890387|JNJ87890387 |
Drug Descriptions |
JNJ-87890387 is a bispecific antibody that targets ENPP3 on tumor cells and CD3 expressed on T-cells, which may induce cytotoxicity against tumor cells expressing ENPP3 and inhibit tumor growth (Cancer Res (2024) 84 (7_Supplement): LB122). |
DrugClasses | CD3 Antibody 103 |
CAS Registry Number | NA |
NCIT ID | C206251 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
JNJ-87890387 | JNJ-87890387 | 0 | 1 |